Cullinan Therapeutics, Inc.
CGEM • NASDAQ
Cullinan Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nadim Ahmed, with a market cap of $920.6M.
Market Cap$920.6M
Employees85.0
CEONadim Ahmed
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Cullinan Therapeutics, Inc. FAQ
Common questions about Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $6.9M.
Cullinan Therapeutics, Inc. has approximately 85 employees.